Public, NASDAQ:ABII
NASDAQ Global Select Market
NeoBiocon, Abraxis Bioscience launch Arbaxan
Date: Fri, 10 Oct 2008 04:27:14 GMT
Tags:
NeoBiocon, Abraxis Bioscience launch Arbaxan
Myiris.com - Oct 10, 2008
Myiris.com - Oct 10, 2008
NeoBiocon , a recently established biotechnology company and Abraxis BioScience , a fully integrated biotechnology company , today announced the launch of ABRAXANE ( paclitaxel protein - bound ...
Abraxis Bioscience Inc (ABII) holdings reduced by Genworth Financial Inc
Date: Sat, 09 Aug 2008 14:04:54 GMT
Tags:
Abraxis Bioscience Inc (ABII) holdings reduced by Genworth Financial Inc
Mffais.com - Aug 9, 2008
Mffais.com - Aug 9, 2008
LONG BEACH ( Mffais . com ) - Genworth Financial Inc sold - 117 ( - 87.31 % ) of their shares in Abraxis Bioscience Inc ( ABII ) , bringing their current holdings to 17 shares as shown by filings ...
Abraxis Bioscience Inc (ABII) more shares bought by Delaware Management Business Trust - Mffais.comAbraxis Bioscience Inc (ABII) newly added by Research Affiliates Llc
Date: Thu, 07 Aug 2008 14:10:17 GMT
Tags:
Abraxis Bioscience Inc (ABII) newly added by Research Affiliates Llc
Mffais.com - Aug 7, 2008
Mffais.com - Aug 7, 2008
LONG BEACH ( Mffais . com ) - Research Affiliates Llc added the Abraxis Bioscience Inc ( ABII ) company to their portfolio , by buying 67,964 shares as shown by filings made public on 2008 - ...
Abraxis Bioscience Inc (ABII) holdings reduced by Vanguard Group Inc
Date: Wed, 06 Aug 2008 11:45:48 GMT
Tags:
Abraxis Bioscience Inc (ABII) holdings reduced by Vanguard Group Inc
Mffais.com - Aug 6, 2008
Mffais.com - Aug 6, 2008
LONG BEACH ( Mffais . com ) - Vanguard Group Inc sold - 201,228 ( - 93.30 % ) of their shares in Abraxis Bioscience Inc ( ABII ) , bringing their current holdings to 14,437 shares as shown by ...
Abraxis Bioscience Inc (ABII) holdings reduced by Dimensional Fund Advisors Inc
Date: Sat, 02 Aug 2008 11:20:06 GMT
Tags:
Abraxis Bioscience Inc (ABII) holdings reduced by Dimensional Fund Advisors Inc
Mffais.com - Aug 2, 2008
Mffais.com - Aug 2, 2008
LONG BEACH ( Mffais . com ) - Dimensional Fund Advisors Inc sold - 25 ( - 0.13 % ) of their shares in Abraxis Bioscience Inc ( ABII ) , bringing their current holdings to 18,865 shares as shown ...
ABRAXIS BIOSCIENCE, INC. Financials (EDGAR Online Financials)
Date: Thu, 9 Oct 2008 13:04:16 Etc/GMT
Tags:
Cenomed and TorreyPines Therapeutics Enter into Licensing Agreement (Business Wire)
Date: Wed, 8 Oct 2008 12:05:00 Etc/GMT
Tags:
IRVINE, Calif. & LA JOLLA, Calif.----Cenomed BioSciences, LLC, a majority-owned subsidiary of Abraxis BioScience, Inc. , and TorreyPines Therapeutics, Inc. today announced that they have entered into an exclusive licensing agreement whereby Cenomed acquired from TorreyPines Therapeutics the worldwide development rights held by TorreyPines to three compounds: phenserine, Posiphen™ and bisnorcymcerine, for chemical defense and counterterrorism defense.
Cancer institute plans to study Abraxis drug (AP)
Date: Tue, 7 Oct 2008 15:34:46 Etc/GMT
Tags:
The National Comprehensive Cancer Network said Tuesday it will conduct studies of Abraxis BioScience Inc.'s breast cancer injection Abraxane for other forms of the disease.
NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies (Business Wire)
Date: Tue, 7 Oct 2008 13:00:00 Etc/GMT
Tags:
FORT WASHINGTON, Pa.----The National Comprehensive Cancer Network , Abraxis BioScience , and AstraZeneca today announced that they have entered into a collaboration to conduct multiple investigator-initiated studies of Abraxis BioScience's anti-cancer drug ABRAXANE® for Injectable Suspension , which is based on the company's proprietary tumor targeting technology known as the nab™ platform.
ABRAXIS BIOSCIENCES, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Date: Fri, 12 Sep 2008 20:16:45 Etc/GMT
Tags: